- Home
- GDEV vs HUMA Comparison
GDEV vs HUMA Comparison
Compare GDEV & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDEV
- HUMA
- Stock Information
- Founded
- GDEV 2009
- HUMA 2004
- Country
- GDEV Cyprus
- HUMA United States
- Employees
- GDEV N/A
- HUMA N/A
- Industry
- GDEV EDP Services
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- GDEV Technology
- HUMA Health Care
- Exchange
- GDEV Nasdaq
- HUMA Nasdaq
- Market Cap
- GDEV 266.7M
- HUMA 250.2M
- IPO Year
- GDEV N/A
- HUMA N/A
- Fundamental
- Price
- GDEV $15.76
- HUMA $1.57
- Analyst Decision
- GDEV Buy
- HUMA Strong Buy
- Analyst Count
- GDEV 1
- HUMA 8
- Target Price
- GDEV $70.00
- HUMA $10.88
- AVG Volume (30 Days)
- GDEV 4.5K
- HUMA 3.2M
- Earning Date
- GDEV 11-13-2025
- HUMA 11-07-2025
- Dividend Yield
- GDEV N/A
- HUMA N/A
- EPS Growth
- GDEV 12.96
- HUMA N/A
- EPS
- GDEV 2.56
- HUMA N/A
- Revenue
- GDEV $425,112,000.00
- HUMA $818,000.00
- Revenue This Year
- GDEV N/A
- HUMA N/A
- Revenue Next Year
- GDEV $11.69
- HUMA $1,619.38
- P/E Ratio
- GDEV $6.35
- HUMA N/A
- Revenue Growth
- GDEV N/A
- HUMA N/A
- 52 Week Low
- GDEV $8.60
- HUMA $1.15
- 52 Week High
- GDEV $42.76
- HUMA $6.77
- Technical
- Relative Strength Index (RSI)
- GDEV 52.42
- HUMA 44.32
- Support Level
- GDEV N/A
- HUMA $1.45
- Resistance Level
- GDEV $18.17
- HUMA $1.53
- Average True Range (ATR)
- GDEV 0.80
- HUMA 0.09
- MACD
- GDEV -0.35
- HUMA 0.04
- Stochastic Oscillator
- GDEV 86.73
- HUMA 65.52
About GDEV GDEV Inc.
GDEV Inc is a gaming and entertainment holding company that oversees a portfolio of studios focused on developing and publishing live-service games across a range of platforms and genres. Its portfolio includes studios specializing in mobile, browser, and PC games, as well as captivating IPs spanning various genres.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.